Pharming CEO Fabrice Chouraqui Steps Down with Immediate Effect
Key Facts
Pharming announced that Fabrice Chouraqui is stepping down as CEO and Executive Director by mutual agreement. GlobeNewswire reported that the CEO's departure is effective immediately as of September 29, 2026.
PHAR closed at $10.52 on September 28, 2026, prior to the announcement of the leadership change. The immediate resignation comes as the company manages its executive transition, following a trading session where the stock reached a high of $10.7 and a low of $10.33.
Latest Updates · 2
- Notable·
Update: Pharming shares declined on September 29, 2026, following revelations that Fabrice Chouraqui's resignation stemmed from a dispute over company strategy. The disclosure triggered selling pressure on the stock following the initial announcement of his immediate departure.
- Notable·
Update: Pharming shares declined on September 29, 2026, following revelations that Fabrice Chouraqui's resignation stemmed from a strategic disagreement. The disclosure regarding the nature of the departure triggered selling pressure after the initial announcement of the mutual agreement.